Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Humacyte (HUMA) Other Operating Expenses (2025)

Humacyte has reported Other Operating Expenses over the past 1 years, most recently at $9.1 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at $9.1 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $9.7 million (changed N/A YoY), and the annual figure for FY2025 was $9.7 million, changed.
  • Other Operating Expenses for Q4 2025 was $9.1 million at Humacyte, up from $260000.0 in the prior quarter.
  • Over the last five years, Other Operating Expenses for HUMA hit a ceiling of $9.1 million in Q4 2025 and a floor of $147000.0 in Q1 2025.